ロード中...
Individualizing anti-metabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status
BACKGROUND: Mutations in the TP53 tumor suppressor gene are common in HNSCC and correlate with radioresistance. Currently, there are no clinically available therapeutic approaches targeting p53 in HNSCC. Here we propose a strategy which uses TP53 mutational status to individualize anti-metabolic str...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3188683/ https://ncbi.nlm.nih.gov/pubmed/21720999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26321 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|